Israel’s Syneron Medical Ltd, a global medical aesthetic device company, has appointed Ilan Nacasch to the newly created position of Chief Brand Officer, effective immediately. He will be responsible for global marketing and branding of all Syneron-Candela products, with a strong focus on supporting the growth of the Body Shaping business in the U.S.
Prior to joining Syneron, Mr. Nacasch served as Chief Marketing Officer of SodaStream International, Ltd., a global manufacturer and marketer of home carbonation systems with a strong focus on consumer marketing. Prior to that, he spent 15 years at Procter & Gamble in marketing positions of increasing responsibility across a range of consumer brands in Europe and the United States. He began his career in marketing at Danone, a global leader in healthy foods.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Amit Meridor, Chief Executive Officer of Syneron, said, “Ilan has deep experience in consumer marketing with a strong track record of leading significant growth initiatives at SodaStream and Procter & Gamble. We ended the year with strong momentum in our business, including strong preliminary fourth quarter revenue results from our launches of UltraShape and PicoWay. Ilan will help us further support this momentum by driving worldwide customer and patient awareness of our unique product portfolio. This will include a major focus on supporting our Body Shaping business in the U.S.”
Syneron Medical Ltd. has a comprehensive product portfolio and a global distribution footprint. The Company boasts that it’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite.
It sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
